Gynaecological Cancers Risk : : Breast Cancer, Ovarian Cancer and Endometrial Cancer / / Ranjit Manchanda.

The International Agency for Research on Cancer suggests that the burden of women's cancers including breast, ovarian, and womb will rise by 50% over the next 20 years. It is essential for us to improve early diagnosis and prevention of these cancers in our health systems. The last decade has s...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
Place / Publishing House:Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2022.
Year of Publication:2022
Language:English
Physical Description:1 online resource (338 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993562237304498
ctrlnum (CKB)4920000001372169
(NjHacI)994920000001372169
(EXLCZ)994920000001372169
collection bib_alma
record_format marc
spelling Manchanda, Ranjit, author.
Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer / Ranjit Manchanda.
Gynaecological Cancers Risk
Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2022.
1 online resource (338 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
The International Agency for Research on Cancer suggests that the burden of women's cancers including breast, ovarian, and womb will rise by 50% over the next 20 years. It is essential for us to improve early diagnosis and prevention of these cancers in our health systems. The last decade has seen significant strides in our ability to understand and predict a woman's risk of these cancers and offer personalized medicine approaches for risk management. There have been improvements in identifying individuals at increased risk, as well as implementing and evaluating strategies for screening and prevention. In this special collection, we bring together 16 articles from leading scientists and researchers. These capture some of the important advances observed in estimating cancer risk, providing genetic testing, offering risk management to those at increased risk, as well as screening and prevention of breast, ovarian, and womb cancers in women. This makes an important contribution to the rapidly advancing knowledge base across the area of personalized medicine and precision prevention of ovarian, endometrial, and breast cancers.
Cancer Risk factors.
Medicine, Preventive.
Public health.
3-0365-2983-7
language English
format eBook
author Manchanda, Ranjit,
spellingShingle Manchanda, Ranjit,
Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer /
author_facet Manchanda, Ranjit,
author_variant r m rm
author_role VerfasserIn
author_sort Manchanda, Ranjit,
title Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer /
title_sub Breast Cancer, Ovarian Cancer and Endometrial Cancer /
title_full Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer / Ranjit Manchanda.
title_fullStr Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer / Ranjit Manchanda.
title_full_unstemmed Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer / Ranjit Manchanda.
title_auth Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer /
title_alt Gynaecological Cancers Risk
title_new Gynaecological Cancers Risk :
title_sort gynaecological cancers risk : breast cancer, ovarian cancer and endometrial cancer /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2022
physical 1 online resource (338 pages)
isbn 3-0365-2983-7
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC268
callnumber-sort RC 3268.48 M363 42022
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.994071
dewey-sort 3616.994071
dewey-raw 616.994071
dewey-search 616.994071
work_keys_str_mv AT manchandaranjit gynaecologicalcancersriskbreastcancerovariancancerandendometrialcancer
AT manchandaranjit gynaecologicalcancersrisk
status_str n
ids_txt_mv (CKB)4920000001372169
(NjHacI)994920000001372169
(EXLCZ)994920000001372169
carrierType_str_mv cr
is_hierarchy_title Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer /
_version_ 1764989440815529984
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02164nam a2200301 i 4500</leader><controlfield tag="001">993562237304498</controlfield><controlfield tag="005">20230223071809.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230223s2022 sz o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000001372169</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994920000001372169</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000001372169</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC268.48</subfield><subfield code="b">.M363 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.994071</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Manchanda, Ranjit,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Gynaecological Cancers Risk :</subfield><subfield code="b">Breast Cancer, Ovarian Cancer and Endometrial Cancer /</subfield><subfield code="c">Ranjit Manchanda.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Gynaecological Cancers Risk </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (338 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The International Agency for Research on Cancer suggests that the burden of women's cancers including breast, ovarian, and womb will rise by 50% over the next 20 years. It is essential for us to improve early diagnosis and prevention of these cancers in our health systems. The last decade has seen significant strides in our ability to understand and predict a woman's risk of these cancers and offer personalized medicine approaches for risk management. There have been improvements in identifying individuals at increased risk, as well as implementing and evaluating strategies for screening and prevention. In this special collection, we bring together 16 articles from leading scientists and researchers. These capture some of the important advances observed in estimating cancer risk, providing genetic testing, offering risk management to those at increased risk, as well as screening and prevention of breast, ovarian, and womb cancers in women. This makes an important contribution to the rapidly advancing knowledge base across the area of personalized medicine and precision prevention of ovarian, endometrial, and breast cancers.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Risk factors.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine, Preventive.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Public health.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2983-7</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-03-01 00:40:00 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-09-22 08:09:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338203510004498&amp;Force_direct=true</subfield><subfield code="Z">5338203510004498</subfield><subfield code="8">5338203510004498</subfield></datafield></record></collection>